References
-
1
Appel L J.
The verdict from ALLHAT-thiazide diuretics are the preferred initial therapy of hypertension.
JAMA.
2002;
288
3039-3042
-
2
Caro J J, Speckman J L, Salas M, Raggio G, Jackson J D.
Effect of initial drug choice on persistence with antihypertensive therapy: The importance of actual practice data.
CMAJ.
1999;
160
41-46
-
3
The ALLHAT officers and coordinators for the ALLHAT collaborative research group .
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).
JAMA.
2002;
288
2981-2997
Prof. Dr., Curt-Engelhorn-Professor of Medicine, Director of the Institute of Clinical Pharmacology Wehling
Faculty of Clinical Medicine Mannheim
University of Heidelberg
Theodor-Kutzer-Ufer
68135 Mannheim
Germany